Navigation Links
Digital Healthcare Announces Cincinnati Eye Institute is Latest Retasure Reading Center
Date:11/26/2007

Country's Largest Ophthalmology Practice Will Assess for Diabetic

Retinopathy, a Leading Cause of Blindness

WAKE FOREST, N.C., Nov. 26 /PRNewswire/ -- Digital Healthcare, a Wake Forest, NC company specializing in retinal risk assessment for diabetics, announced today that Cincinnati Eye Institute (CEI) is the latest ophthalmology clinic to connect with the Retasure retinal imaging system.

CEI is the largest ophthalmology practice in the United States with over 45 doctors across 20 locations. Founded over 50 years ago, CEI is today considered one of the world's premier ophthalmic treatment, research and education centers. CEI has internationally recognized specialists in virtually every ophthalmologic sub-specialty. Each subspecialty group participates in cutting edge development and ongoing clinical studies, and collectively CEI physicians set the standard for state of the art vision care.

"We are proud that such a prestigious facility as Cincinnati Eye Institute will partner as a Retasure reading center," said Scott Sanner, Senior Vice President, North American Operations of Digital healthcare. "Cincinnati Eye is committed to providing the highest level of eye care to enhance the quality of patients' lives. Their physicians share our belief that providing patients greater access to eye assessments helps in the fight against diabetic retinopathy and blindness."

"Cincinnati Eye Institute has long set the standard for advanced eye care," said Daniel M. Miller, M.D., Ph.D. "Retasure provides a solution that truly enhances patient care by making retinal assessments for diabetics readily available. Fewer than 50% of the country's 21 million diabetics have annual eye exams, but Retasure allows primary care physicians to capture retinal images in their offices. Retinal specialists are able to remotely evaluate these images, and ultimately the process ensures high-risk patients have an accurate and timely referral to an eye-care specialist."

The FDA-approved Retasure program provides a simple, affordable, and non-invasive solution that allows physicians to capture their patients' retinal images during a three to five minute procedure. Images are transmitted over a secure, HIPPA compliant network to an accredited reading center. A state-licensed and board certified ophthalmologist reviews the images and results are returned to the original physician within 72 hours.

There are an estimated 21 million diabetic patients in the US, but only about half have any retinal assessments, despite a high risk of diabetic retinopathy. The National Eye Institute indicates diabetic retinopathy is the leading cause of blindness among working age American adults. More than a million patients around the world have received a retinal risk assessment using Digital Healthcare software.

About Digital Healthcare

Digital Healthcare is the global leader in retinal risk assessment. They are the world's leading provider of care management programs for diabetic retinopathy. Their award-winning MS-HUG technology is used by leading hospitals and research centers including University Hospitals Case Medical Center at Case Western Reserve University, The Wilmer Eye Institute at The Johns Hopkins University and the United States Military. Digital Healthcare's Retasure solution offers several advantages for primary care and endocrinologist physicians and their patients: It can be operated by non-clinicians; it is non-invasive and requires no dilation; it obtains exceptionally high-quality digital images of the retina using a simple-to-operate fundus camera; it returns results quickly to the ordering physicians; and it encourages patient compliance for retinal evaluation and comprehensive eye examinations.


'/>"/>
SOURCE Digital Healthcare
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
2. Digital pioneer wins national physics prize
3. Rapid Quantification of Osteoarthritis With a Novel, Office-Based, High-Resolution Digital Imaging Device
4. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
5. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
8. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
9. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
(Date:3/23/2017)... According to a report by Transparency Market Research (TMR), ... the presence of a large pool of participants; however, only a ... Sigma-Aldrich, compete with each other in this market. With Proliant being ... of this market in 2016.  ... As of now, a large number of vendors are ...
(Date:3/23/2017)... NEW YORK , March 23, 2017 ... closer look at four equities in the Biotech industry: ... EYEG), Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus ... March 21 st , 2017, Credit Suisse upgraded its rating ... stocks by downloading their free report at: ...
(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
Breaking Biology Technology:
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ... Iris-Scan, wird seine erstklassige biometrische Lösung zur ... 835 mit X16 LTE auf dem Mobile ... März) am Qualcomm-Stand in Halle 3, Stand ... beinhaltet die Sicherheitsplattform Qualcomm Haven™ – eine ...
(Date:2/26/2017)...  Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring, announces the appointment of ... "Too often, too many offenders return to jail ... trying to tackle this ongoing problem and improve ... members. While significant steps are underway, Securus continues to ...
(Date:2/22/2017)... 22, 2017 With the biometrics market ... identifies four technologies that innovative and agile startups ... share in the changing competitive landscape: multifactor authentication ...   "Companies can no longer afford ... says Dimitrios Pavlakis , Industry Analyst at ...
Breaking Biology News(10 mins):